CXCL13 and neoplasm: These findings highlight the differential interaction networks between CXCL13+ T cells and myeloid cells in recurrent versus non-recurrent tumors, providing valuable insights into the mechanisms underlying tumor recurrence following CCRT treatment in patients with CSCC.